When testing the aura6000 implant, LivaNova didn’t exclude patients who have historically been seen as poor candidates.| Sleep Review
Physicians show ‘strong demand’ for the neurostimulator for obstructive sleep apnea patients, says Nyxoah CEO.| Sleep Review
The USPTO has awarded Nexalin Technology Inc a new patent relating to its method of use, which covers key aspects of the technology that enables patients to receive treatment from the privacy of their homes.| Sleep Review